MD

Medcamp SAWSE Medcamp Stock Report

Last reporting period 30 Sep, 2023

Updated 31 Oct, 2024

Last price

Market cap $B

0.001

Micro

Exchange

XWAR - Warsaw Stock Exchange

MDP.WA Stock Analysis

MD

Uncovered

Medcamp SA is uncovered by Eyestock quantitative analysis.

Market cap $B

0.001

Dividend yield

Shares outstanding

26.15 B

MEDCAMP SA provides research and development services in the field of biotechnology. The company is headquartered in Poznan, Woj. Wielkopolskie. The company went IPO on 2007-11-16. The firm is involved in the acquisition, management, redevelopment and upgrade, as well as rental and sale of commercial properties, including office areas and warehouses. In addition, the Company is involved in long-term investments in construction and real estate entities. The company conducts rental and redevelopment projects, such as Poznan, Jasielska; Poznan, Komorniki; Poznan, Jasielska, Inkubator; Szamotuly, Dworcowa; among others. The firm aims to build a research and development center in Poznan, specializing in such areas as personalized medicine, genetics, genomics and bioinformatics, supported by artificial intelligence, The Company operates through subsidiaries, including T2 Inkubator Sp z o o, T2 Szamotuly Sp z o o, Polskie Centrum Badan i Rozwoju Sp z o o, among others. The majority shareholder of the Company is Moonrock Enterprise SA.

View Section: Eyestock Rating